Quantitative proteomics using formalin-fixed paraffin-embedded tissues of oral squamous cell carcinoma

Cancer Science

Volumn 100, Issue 9, 2009, Pages 1605-1611

  Negishi, Ayako ^a,b   Masuda, Mari ^a   Ono, Masaya ^a   Honda, Kazufumi ^a   Shitashige, Miki ^a   Satow, Reiko ^a   Sakuma, Tomohiro ^c   Kuwabara, Hideya ^c   Nakanishi, Yukihiro ^a   Kanai, Yae ^a   Omura, Ken ^b   Hirohashi, Setsuo ^a   Yamada, Tesshi ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c Mitsui Knowledge Industry Co   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FORMALDEHYDE; MESSENGER RNA; PARAFFIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEOME; TGM3 PROTEIN, HUMAN; TUMOR PROTEIN;

ARTICLE; CHEMISTRY; DNA METHYLATION; ENZYME IMMUNOASSAY; FEMALE; GENE SILENCING; GENETIC EPIGENESIS; GENETICS; HUMAN; IMMUNOBLOTTING; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; METABOLISM; MICRODISSECTION; MIDDLE AGED; PATHOLOGY; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TISSUE FIXATION; TONGUE TUMOR; TUMOR CELL CULTURE; WESTERN BLOTTING;

BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CHROMATOGRAPHY, LIQUID; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; FORMALDEHYDE; GENE SILENCING; HUMANS; IMMUNOBLOTTING; IMMUNOENZYME TECHNIQUES; MALE; MICRODISSECTION; MIDDLE AGED; NEOPLASM PROTEINS; PARAFFIN EMBEDDING; PROTEOME; PROTEOMICS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TISSUE FIXATION; TONGUE NEOPLASMS; TRANSGLUTAMINASES; TUMOR CELLS, CULTURED;

EID: 70149108744     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01227.x     Document Type: Article

References (34)

1. Forastiere A, Koch W, Trotti A, Sidransky D. Head and neck cancer. N Engl J Med 2001; 345: 1890-900.
2. Spitz MR. Epidemiology and risk factors for head and neck cancer. Semin Oncol 1994; 21: 281-8.
3. Franceschi D, Gupta R, Spiro RH, Shah JP. Improved survival in the treatment of squamous carcinoma of the oral tongue. Am J Surg 1993; 166: 360-5.
4. Mackenzie J, Ah-See K, Thakker N et al. Increasing incidence of oral cancer amongst young persons: what is the aetiology? Oral Oncol 2000; 36: 387-9.
5. Annertz K, Anderson H, Biorklund A et al. Incidence and survival of squamous cell carcinoma of the tongue in Scandinavia, with special reference to young adults. Int J Cancer 2002; 101: 95-9.
6. Schantz SP, Yu GP. Head and neck cancer incidence trends in young Americans, 1973-97, with a special analysis for tongue cancer. Arch Otolaryngol Head Neck Surg 2002; 128: 268-74.
7. Yamaguchi U, Nakayama R, Honda K et al. Distinct gene expression-defined classes of gastrointestinal stromal tumor. J Clin Oncol 2008; 26: 4100-8.
8. Ahram M, Flaig MJ, Gillespie JW et al. Evaluation of ethanol-fixed, paraffin- embedded tissues for proteomic applications. Proteomics 2003; 3: 413-21.
9. Patel V, Hood BL, Molinolo AA et al. Proteomic analysis of laser-captured paraffin-embedded tissues: a molecular portrait of head and neck cancer progression. Clin Cancer Res 2008; 14: 1002-14.
10. Hwang SI, Thumar J, Lundgren DH et al. Direct cancer tissue proteomics: a method to identify candidate cancer biomarkers from formalin-fixed paraffin- embedded archival tissues. Oncogene 2007; 26: 65-76.
11. Ono M, Shitashige M, Honda K et al. Label-free quantitative proteomics using large peptide data sets generated by nanoflow liquid chromatography and mass spectrometry. Mol Cell Proteomics 2006; 5: 1338-47.
12. Honda K, Yamada T, Hayashida Y et al. Actinin-4 increases cell motility and promotes lymph node metastasis of colorectal cancer. Gastroenterology 2005; 128: 51-62.
13. Shitashige M, Naishiro Y, Idogawa M et al. Involvement of splicing factor-1 in β-catenin/T-cell factor-4-mediated gene transactivation and pre-mRNA splicing. Gastroenterology 2007; 132: 1039-54.
14. Huang L, Shitashige M, Satow R et al. Functional interaction of DNA topoisomerase IIα with the β-catenin and T-cell factor-4 complex. Gastro- enterology 2007; 133: 1569-78.
15. He G, Zhao Z, Fu W, Sun X, Xu Z, Sun K. [Study on the loss of heterozygosity and expression of transglutaminase 3 gene in laryngeal carcinoma]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2002; 19: 120-3. (In Chinese.)
16. Gonzalez HE, Gujrati M, Frederick M et al. Identification of 9 genes differentially expressed in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2003; 129: 754-9.
17. Choi P, Jordan CD, Mendez E et al. Examination of oral cancer biomarkers by tissue microarray analysis. Arch Otolaryngol Head Neck Surg 2008; 134: 539-46.
18. Kondoh N, Ishikawa T, Ohkura S et al. Gene expression signatures that classify the mode of invasion of primary oral squamous cell carcinomas. Mol Carcinog 2008; 47: 744-56.
19. Ye H, Yu T, Temam S et al. Transcriptomic dissection of tongue squamous cell carcinoma. BMC Genomics 2008; 9: 69.
20. Mendez E, Fan W, Choi P et al. Tumor-specific genetic expression profile of metastatic oral squamous cell carcinoma. Head Neck 2007; 29: 803-14.
21. Ohkura S, Kondoh N, Hada A et al. Differential expression of the keratin-4-13-14-17 and transglutaminase 3 genes during the development of oral squamous cell carcinoma from leukoplakia. Oral Oncol 2005; 41: 607-13.
22. Liu W, Yu ZC, Cao WF, Ding F, Liu ZH. Functional studies of a novel oncogene TGM3 in human esophageal squamous cell carcinoma. World J Gastroenterol 2006; 12: 3929-32.
23. Uemura N, Nakanishi Y, Kato H et al. Transglutaminase 3 as a prognostic biomarker in esophageal cancer revealed by proteomics. Int J Cancer 2009; 124: 2106-15.
24. Uchikado Y, Inoue H, Haraguchi N et al. Gene expression profiling of lymph node metastasis by oligomicroarray analysis using laser microdissection in esophageal squamous cell carcinoma. Int J Oncol 2006; 29: 1337-47.
25. Griffin M, Casadio R, Bergamini CM. Transglutaminases: nature's biological glues. Biochem J 2002; 368: 377-96.
26. Lorand L, Graham RM. Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol 2003; 4: 140-56.
27. Esposito C, Caputo I. Mammalian transglutaminases. Identification of substrates as a key to physiological function and physiopathological relevance. FEBS J 2005; 272: 615-31.
28. Lee JH, Jang SI, Yang JM, Markova NG, Steinert PM. The proximal promoter of the human transglutaminase 3 gene. Stratified squamous epithelial-specific expression in cultured cells is mediated by binding of Sp1 and ets transcription factors to a proximal promoter element. J Biol Chem 1996; 271: 4561-8.
29. Hitomi K, Horio Y, Ikura K, Yamanishi K, Maki M. Analysis of epidermal- type transglutaminase (TGase 3) expression in mouse tissues and cell lines. Int J Biochem Cell Biol 2001; 33: 491-8.
30. Kim SY, Chung SI, Steinert PM. Highly active soluble processed forms of the transglutaminase 1 enzyme in epidermal keratinocytes. J Biol Chem 1995; 270: 18026-35.
31. Mack JA, Anand S, Maytin EV. Proliferation and cornification during develop- ment of the mammalian epidermis. Birth Defects Res C Embryo Today 2005; 75: 314-29.
32. Nakaoka H, Perez DM, Baek KJ et al. Gh: a GTP-binding protein with transglutaminase activity and receptor signaling function. Science 1994; 264: 1593-6.
33. Hitomi K, Ikura K, Maki M. GTP, an inhibitor of transglutaminases, is hydrolyzed by tissue-type transglutaminase (TGase 2) but not by epidermal- type transglutaminase (TGase 3). Biosci Biotechnol Biochem 2000; 64: 657-9.
34. Kim SY, Jeitner TM, Steinert PM. Transglutaminases in disease. Neurochem Int 2002; 40: 85-103.